Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0025362 (
mental retardation
)
15,878
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Gene localization was determined by linkage analysis in 5 families with non-specific X-linked
mental retardation
(MRX) and were
MRX1
, Xp11.4-q21.31; MRX10, Xp21.3-p11.4; MRX11, Xp21.3-p11.22; MRX12, Xp21.3-q21.1; and MRX13, Xp22.3-q21.22. Four of these localizations cross the dystrophin brain promoter, a candidate locus for MRX. None of the affected individuals who were tested showed variation suggestive of a deletion. No consistent clinical features were observed between or within 4 of the 5 families. In MRX12, prematurity or low birth weight, hypotelorism and short stature were seen in several affected males. Heterozygote manifestations occurred in 3 families. There was no evidence to suggest involvement of the same gene in more than one family, nor to clinically separate these families into distinct genetic entities. Non-overlapping localizations for
MRX1
and MRX10 demonstrate the existence of at least 2 separate loci among these 5 families.
...
PMID:Localization of non-specific X-linked mental retardation genes. 160 17
Nomenclature guidelines are proposed for non-specific and for syndromal forms of X-linked
mental retardation
. Non-specific mental retardations (MRX) are given unique symbols for each family (
MRX1
, MRX2, MRX3 ...). Syndromal mental retardations (MRXS) which do not as yet have specific symbols are given unique interim symbols for each syndrome (MRXS1, MRXS2, MRXS3 ...). The prerequisite for assignment of serial MRX and MRXS gene symbols is a minimum lod score (or multipoint lod score) of +2 between the MR locus and one or more X chromosome markers. Prior approval of availability for proposed gene symbols must be obtained from the Nomenclature Committee of the Human Gene Mapping Workshops.
...
PMID:Nomenclature guidelines for X-linked mental retardation. 160 16
A family is described with five affected males segregating a new gene for non-specific X linked
mental retardation
(MRX). Linkage analysis localised the gene at Xq28-qter. The maximum lod score was 2.89 with DXS52 (St14) at theta = 0.0. A recombinant was observed with DXS304 (U6.2) defining the proximal limit to the localisation. No evidence for linkage was determined using markers at several points along the remainder of the X chromosome, including the regions known to contain
MRX1
and MRX2. This delineates the third gene for non-specific X linked
mental retardation
, MRX3.
...
PMID:Localisation of the MRX3 gene for non-specific X linked mental retardation. 187 93
Linkage analysis was carried out in a large four-generation German family segregating for non-specific X-linked
mental retardation
. Affected males have moderate intellectual handicap. Speech delay, deviant behaviour, and hyperactivity have also been reported. Head circumference and testicular volumes are normal. Cytogenetic analysis failed to show evidence for fragile site or structural abnormality of the X chromosome. None of the obligatory carriers shows any clinical symptoms. Close linkage without recombination (lod scores 1.74 to 2.05) has been found between the disease locus (
MRX1
) and the polymorphic DNA loci DXS7 (Xp11.4-p11.3), MAOA (Xp11.3-p11.23), DXS255 (Xp11.22), and DXS159 (Xq12) suggesting that the gene responsible for the disease in this family maps in the pericentromeric region of the X chromosome. Linkage data obtained with the flanking marker loci OTC (Xp21.1) and DXS95 (Xq21.2-q21.3) also were compatible with this localization of the
MRX1
gene. Close linkage to loci from Xp22, Xq22, Xq24-25, or Xq28 could be excluded.
...
PMID:Gene for non-specific X-linked mental retardation maps in the pericentromeric region. 201 62
An analysis of the linkage of a non-syndromal form of X-linked
mental retardation
(
MRX1
) with a number of markers on the X chromosome was performed in a large pedigree. The affected males had moderate mental retardation; in all other clinical respects and cytogenetically they were normal. No recombinants were observed between the
MRX1
gene and the marker DXS14 (p58.1) located at Xp11-cen (Z (max.) = 2.12 at theta = 0.00). Recombination was observed between the
MRX1
gene and the markers DXS7 and DXYS1 which flank DXS14. This form of XLMR maps to the centromeric portion of the X-chromosome.
...
PMID:A non-syndromal form of X-linked mental retardation (XLMR) is linked to DXS14. 317 66
M6 is a neuronal membrane glycoprotein that may have an important role in neural development. This molecule was initially defined by a monoclonal antibody that affected the survival of cultured cerebellar neurons and the outgrowth of neurites. The nature of the antigen was discovered by expression cDNA cloning using this monoclonal antibody. Two distinct murine M6 cDNAs (designated M6a and M6b) whose deduced amino acid sequences were remarkably similar to that of the myelin proteolipid protein were previously isolated. We have isolated partial human cDNA and genomic clones encoding M6a and M6b and have characterized them by restriction mapping, Southern hybridization with cDNA probes, and sequence analysis. We have localized these genes within the human genome by FISH (fluorescence in situ hybridization). The human M6a gene is located at 4q34, and the M6b gene is located at Xp22.2. A number of human neurological disorders have been mapped to the Xp22 region, including Aicardi syndrome (MIM 304050), Rett syndrome (MIM 312750), X-linked Charcot-Marie-Tooth neuropathy (MIM 302801), and X-linked
mental retardation
syndromes (
MRX1
, MIM 309530). This raises the possibility that a defect in the M6b gene is responsible for one of these neurological disorders.
...
PMID:Chromosomal mapping of the human M6 genes. 866 Oct 15
A gene responsible for X-linked
mental retardation
with macrocephaly and seizures (MRX38) in a family with five affected males in three generations was localized to Xp21.1-p22.13 by linkage analysis. Recombination events placed the gene between DXS1226 distally and DXS1238 proximally, defining an interval of approximately 14 cM. A peak lod score of 2.71 was found with several loci in Xp21.1 (DXS992, DXS1236, DXS997, and DXS1036) at a recombination fraction of zero. The map intervals of 5 X-linked
mental retardation
loci, MRX2 (Xp22.1-p22.2), MRX19 (Xp22),
MRX21
(Xp21.1-p22.3), MRX29 (Xp21.2-p22.1), and MRX32 (Xp21.2-p22.1), and two syndromal
mental retardation
loci, Partington syndrome (PRTS; Xp22) and Coffin-Lowry syndrome (CLS; Xp22.13-p22.2), overlap this region. As none of these display the same phenotype seen in the family reported here, this X-linked
mental retardation
locus may represent a new entity.
...
PMID:Regional localization of an X-linked mental retardation gene to Xp21.1-Xp22.13 (MRX38). 882 57
Two genes responsible for X-linked
mental retardation
have been localised by linkage analysis. MRX30 maps to a 28 cM region flanked by the loci DXS990 (Xq21.3) and DXS424 (Xq24). A significant multipoint lod score of 2.78 was detected between the loci DXS1120 and DXS456. MRX31 maps to a 12 cM region that spans the centromere from DXS1126 (Xp11.23) to DXS1124 (Xq13.3). Significant two-point lod scores, at a recombination fraction of zero, were obtained with the loci DXS991 (Zmax = 2.06), AR (Zmax = 3.44), PGK1P1 (Zmax = 2.06) and DXS453 (Zmax = 3.31). The MRX30 localisation overlaps that of MRX8, 13, 20 and 26 and defines the position of a new MRX gene on the basis of a set of non-overlapping regional localisations. The MRX31 localisation overlaps the localisations of many of the pericentromeric MRX loci (MRX 1, 4, 5, 7, 8, 9, 12, 13, 14, 15, 17, 20, 22 and 26). There are now at least 8 distinct loci associated with non-specific
mental retardation
on the X chromosome defined, in order from pter to qter, by localisation for MRX24, MRX2, MRX10,
MRX1
, MRX30, MRX27, FRAXE and MRX3.
...
PMID:Regional localisation of two non-specific X-linked mental retardation genes (MRX30 and MRX31). 882 60
X-linked
mental retardation
is estimated to affect approximately 1 in 600 males. Although numerous genes responsible for syndromic
mental retardation
have been identified, the study of non-syndromic
mental retardation
suffers from intrinsic issues of genetic heterogeneity. During the investigation of three brothers with a contiguous gene deletion syndrome of Becker muscular dystrophy, glycerol kinase deficiency, congenital adrenal hypoplasia, and
mental retardation
, we found their dystrophin gene to be fused tail-to-tail with a gene encoding a novel member of the interleukin-1 receptor family,
IL1RAPL1
. This gene has a close relative in Xq22, which we call IL1RAPL2. Both
IL1RAPL1
and IL1RAPL2 have novel C-terminal sequences not present in other related proteins, and are encoded by very large genes. The 1.8-megabase deletion in these patients removes not only the last exon of the dystrophin gene, the entire glycerol kinase and DAX-1 genes, and the MAGE-B gene cluster, but also three exons encoding the intracellular signalling domain of
IL1RAPL1
. The literature contains multiple reports of patients with non-syndromic
mental retardation
in association with an Xp22.1-Xp21.3 microdeletion of a marker which lies within the
IL1RAPL1
gene. The gene is also wholly or partially deleted in patients with
mental retardation
as part of a contiguous deletion syndrome. We suggest that
IL1RAPL1
, and perhaps IL1RAPL2, are strong candidates for X-linked non-syndromic
mental retardation
loci, and that molecules resembling IL-1 and IL-18 play a role in the development or function of the central nervous system.
...
PMID:Two novel members of the interleukin-1 receptor gene family, one deleted in Xp22.1-Xp21.3 mental retardation. 1075 39
We report on a mother and daughter both with a 45,X/46,X,r(X)(p22. 3q28) karyotype and
mental retardation
. Fluorescence in situ hybridization (FISH) and microsatellite analyses for 14 loci/region at Xp22.3 and seven loci/region at Xq28 indicated that the ring X chromosome was missing a roughly 12-Mb region from Xp22.3 with the breakpoint between DXS85 and DXS9972, and another region of less than 100 kb from Xq28 with the breakpoint distal to the region defined by the FISH probe c8.2/1. X-inactivation analysis, using the methylation status of the AR gene (exon 1) as an indicator, showed that the normal and ring X chromosomes in the X,r(X)(p22.3q28) cell lineage were randomly inactivated. The Xp22.3 deleted region partially overlaps with the regional intervals of MRX19,
MRX21
, MRX24, MRX37, MRX43, and MRX49 associated with heterozygote manifestation. Therefore, it is likely that one or more of these MRX genes, subject to X-inactivation, are lost from the ring X chromosome, and that reduced expression of the MRX gene(s) caused by random X-inactivation has resulted in
mental retardation
in the mother and daughter.
...
PMID:Mother and daughter with 45,X/46,X,r(X)(p22.3q28) and mental retardation: analysis of the X-inactivation patterns. 1076 81
1
2
3
Next >>